School-wide Response to Intervention (RTI) services are growing in prevalence in U.S. schools. Most advanced are RTI programs in elementary schools, with preschool and secondary education programs beginning to discuss, develop, and experiment with school-wide RTI. At its heart, RTI seeks to account for individual differences in student learning success by discovering the instructional situations in which each student learns best and providing them for all who need them. RTI is an early intervening approach to the prevention of learning and behavior problems before they become disabilities later. The implementation of school-wide RTI approaches reorganizes school ecology at multiple levels and when implemented with fidelity, RTI schools have a distinctive "ecological footprint" that differentiates them from traditional, non-RTI schools. Implementers of RTI need consultation that provides them with information on the structure and function of their programs for use in problem solving and decision making. The purpose of this paper is to describe RTI and illustrate an ecobehavioral approach to providing RTI school staff with information they need.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026207 | PMC |
http://dx.doi.org/10.1080/10474412.2011.649648 | DOI Listing |
Am J Sports Med
January 2025
Department of Orthopaedic Surgery, Sports Medicine Institute, Hospital for Special Surgery, New York, New York, USA.
Background: Randomized controlled trials (RCTs) evaluating the efficacy of platelet-rich plasma (PRP) for the management of lateral epicondylitis (LE) have been characterized by substantial variability in reported outcomes. The source of this heterogeneity is uncertain.
Purpose: To determine the effect of estimated platelet concentration on the efficacy of PRP for the management of LE.
Drug Alcohol Depend Rep
March 2025
Department of Medicine, University of Washington, Seattle, WA, USA.
Aim: Unhealthy alcohol use is often correlated with experiences of intimate partner violence (IPV). We investigated how different types of IPV (sexual, physical, emotional, and financial) were associated with unhealthy alcohol use among women engaged in sex work in Mombasa, Kenya.
Methods: This cross-sectional study included 283 HIV-negative women who engaged in sex work recruited from an ongoing cohort study.
Future Oncol
January 2025
Bristol Myers Squibb, Princeton, NJ, USA.
Aim: Assess real-world fedratinib (FEDR) treatment patterns and clinical outcomes in patients with primary or secondary myelofibrosis following discontinuation of ruxolitinib (RUX).
Patients & Methods: This study was a retrospective, noninterventional medical record review of patients in Canada, Germany, and the United Kingdom (UK). A total of 70 physicians (primarily hematologist-oncologists [78.
Sci Data
January 2025
RTI International, 3040 Cornwallis Rd., P.O. Box 12194, Research Triangle Park, NC, 27709, USA.
Geospatially explicit and statistically accurate person and household data allow researchers to study community-and neighborhood-level effects and design and test hypotheses that would otherwise not be possible without the generation of synthetic data. In this article, we demonstrate the workflow for generating spatially explicit household- and individual-level synthetic populations for the United States representing the year 2019. We use publicly available U.
View Article and Find Full Text PDFJACC Adv
January 2025
Center for Cardiovascular Disease Prevention, Divisions of Preventive Medicine and Cardiovascular Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Background: Serum urate (SU) associates with cardiovascular (CV) events, mortality, and gout.
Objectives: The purpose of this study was to assess whether SU predicts CV risk in a trial of interleukin (IL)-1β inhibition with canakinumab, and whether IL-1β blockade, kidney function, or gout alter these associations.
Methods: This study is a subanalysis of the Canakinumab Antiinflammatory Thrombosis Outcome Study (CANTOS), which randomized 10,061 patients with prior myocardial infarction and elevated high-sensitivity C-reactive protein to 3 doses of canakinumab or placebo.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!